UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 16, 2016 4:30 P.M.
Form: S-3
CIK: 0001581720
Company Name: Loxo Oncology, Inc.
File Number: 333-214392